Buteyko Asthma Management



  Introduction
 
 
How Does it Work
 
About the Program
 
How to Learn Buteyko
 
Case Studies
 
Media Coverage
 
Medical Trials
 
About Us
 
Resources
 

- - - - - -
Join the Buteyko Mailing List
- - - - - -
 
medical trials In this Section

    Introduction

 
Doctor's Comments
 
Future Research
 

Related Links
 
    The Brisbane Trials

 
Self-Management of Asthma through Normalisation of Breathing
 
The Brisbane trial is the best western study of the Buteyko Method. The trial results indicated asthmatics using the Buteyko Method reduced use of beta-agonists (relievers) by 96% and steroids by 49%.

The trials were sponsored by the Australian Association of Asthma Foundations and lead by Professor Charles Mitchell, and Doctor Simon Bowler

In the study, 19 randomly selected asthmatics learned the Buteyko Method and 20 other asthmatics learned standard physiotherapy exercises. The group taught the Buteyko Method significantly reduced their beta-agonist intake, improved control over their asthma, and improved quality of life.

Bronchodilator Reduction
At the 12 week mark the group practising Buteyko exercises had reduced their bronchodilator (reliever) medication by 96%, whereas the control group had no significant improvement. Bronchodilator Reduction Graph
 
 
Inhaled Steroid Reduction
The Buteyko Breathing Method allowed asthmatics to reduce their anti-inflammatory medication by 49% over three months, whereas the control group had no reduction.

Inhaled Steroids Graph
 
Breathing Rates
The initial clinical testing demonstrated that all participants at rest hyperventilated. The Buteyko techniques teach asthma sufferers to reduce their breathing to normal levels.

Buteyko subjects reduced their hyperventilation by an average of 31% in their minute volume at twelve weeks. There was no significant change in the control group.

Minute Volume Graph

There was a correlation between the relative reduction in need for bronchodilators and the proportionate reduction in minute volumes in Buteyko subjects; that is, the subject's need for bronchodilator medication was related to the volume of air they breathed. The more air an individual breathed, the more bronchodilator that person needed.

  
This research supports:

a) the known link between hyperventilation and asthma

b) the effectiveness of the Buteyko Method in normalising breathing

c) the relationship between the normalisation of breathing and the reduced need for medication
 

  

The outcome of the Brisbane trial has led the Australian National Asthma Campaign to include Buteyko in their next doctor's asthma Mangement Handbook, giving official blessing to the Buteyko Method.

At present, similar trials are planned in New Zealand, Australia, and the UK. The Victorian Asthma Foundation has made AUD$20,000 available for further research into Buteyko.

Click here to read a full version of the trial published in the Australian Medical Journal.

Print This

next

home  about buteyko  research your asthma  sleep problems  products  our courses  contact us


Copyright © 1999, Buteyko Asthma Management. All rights reserved.
This information is not intended to be a substitute for professional medical advice. You should not use this information to diagnose or treat a health problem or disease without consulting with a qualified healthcare provider. Please consult your healthcare provider with any questions or concerns you may have regarding your condition.


Contact Us Our Courses Products Research your Asthma About Buteyko